Outcomes at age 14 yrs | Whole population | Males | Females | ||||||
Subjects n/N | OR (95% CI) | p-value | Subjects n/N | OR (95% CI) | p-value | Subjects n/N | OR (95% CI) | p-value | |
BHR | 236/1286 | 0.35 (0.13–0.95) | 0.039 | 104/666 | 0.33 (0.07–1.48) | 0.148 | 132/620 | 0.44 (0.11–1.69) | 0.232 |
Atopy | 827/1379 | 0.49 (0.23–1.06) | 0.071 | 465/713 | 0.22 (0.07–0.67) | 0.008 | 362/666 | 0.79 (0.27–2.34) | 0.672 |
HDM sensitisation | 540/1379 | 0.36 (0.16–0.77) | 0.009 | 311/713 | 0.20 (0.07–0.59) | 0.004 | 229/666 | 0.51 (0.16–1.60) | 0.248 |
Actual vitamin D at age 14 yrs (in nmol·L−1) was log10-transformed and included in univariate logistic regression analyses for outcomes at age 14 yrs. Forced expiratory volume in 1 s/forced vital capacity ratio <80% was the criterion used to define poor lung function at age 14 yrs. n: total subjects in regression; N: subjects in regression with outcome; BHR: bronchial hyperresponsiveness; HDM: house dust mite.